COVID-19 vaccination: effective utilization of low dead space (LDS) syringes

Int J Infect Dis. 2021 Dec:113:90-92. doi: 10.1016/j.ijid.2021.09.068. Epub 2021 Sep 29.

Authors

Jun Shinozuka¹, Michiaki Hata², Hiromi Eguchi¹, Masahiro Mori³, Mitsunori Eguchi⁴, Mototaka Fukui⁵, Natsuki Sai⁵, Shinsaku Imashuku⁶, Atsushi Sueyoshi⁷

Affiliations

¹ Infection Control Committee.
² Division of Emergency and Critical Care Medicine.
³ Infection Control Committee; Department of Laboratory Medicine.
⁴ Department of Laboratory Medicine.
⁵ Division of Respiratory Medicine.
⁶ Department of Laboratory Medicine. Electronic address: shinim95@mbox.kyoto-inet.or.jp.
⁷ Director, Uji-Tokushukai Medical Center, Uji, Kyoto 611-0041, Japan.

No abstract available

Keywords: COVID-19; Pfizer vaccine; effective utilization; low dead space syringe.

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Syringes*
Vaccination

Substances

COVID-19 Vaccines